197 related articles for article (PubMed ID: 36845135)
1. An
Gastoldi S; Aiello S; Galbusera M; Breno M; Alberti M; Bresin E; Mele C; Piras R; Liguori L; Santarsiero D; Benigni A; Remuzzi G; Noris M
Front Immunol; 2023; 14():1112257. PubMed ID: 36845135
[TBL] [Abstract][Full Text] [Related]
2. Modeling complement activation on human glomerular microvascular endothelial cells.
Stevens KH; Baas LM; van der Velden TJAM; Bouwmeester RN; van Dillen N; Dorresteijn EM; van Zuilen AD; Wetzels JFM; Michels MAHM; van de Kar NCAJ; van den Heuvel LP
Front Immunol; 2023; 14():1206409. PubMed ID: 37954621
[TBL] [Abstract][Full Text] [Related]
3. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
Galbusera M; Noris M; Gastoldi S; Bresin E; Mele C; Breno M; Cuccarolo P; Alberti M; Valoti E; Piras R; Donadelli R; Vivarelli M; Murer L; Pecoraro C; Ferrari E; Perna A; Benigni A; Portalupi V; Remuzzi G
Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
[TBL] [Abstract][Full Text] [Related]
4. Molecular Studies and an
Piras R; Iatropoulos P; Bresin E; Todeschini M; Gastoldi S; Valoti E; Alberti M; Mele C; Galbusera M; Cuccarolo P; Benigni A; Remuzzi G; Noris M
Front Med (Lausanne); 2020; 7():579418. PubMed ID: 33224962
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
Noris M; Galbusera M; Gastoldi S; Macor P; Banterla F; Bresin E; Tripodo C; Bettoni S; Donadelli R; Valoti E; Tedesco F; Amore A; Coppo R; Ruggenenti P; Gotti E; Remuzzi G
Blood; 2014 Sep; 124(11):1715-26. PubMed ID: 25037630
[TBL] [Abstract][Full Text] [Related]
6. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
Goicoechea de Jorge E; Tortajada A; García SP; Gastoldi S; Merinero HM; García-Fernández J; Arjona E; Cao M; Remuzzi G; Noris M; Rodríguez de Córdoba S
J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505
[TBL] [Abstract][Full Text] [Related]
7. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
[TBL] [Abstract][Full Text] [Related]
8. Genotypic analysis of a large cohort of patients with suspected atypical hemolytic uremic syndrome.
Connaughton DM; Bhai P; Isenring P; Mahdi M; Sadikovic B; Schenkel LC
J Mol Med (Berl); 2023 Aug; 101(8):1029-1040. PubMed ID: 37466676
[TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study.
Duineveld C; Bouwmeester RN; van den Heuvel LPWJ; van de Kar NCAJ; Wetzels JFM
Kidney Int Rep; 2024 Jan; 9(1):145-151. PubMed ID: 38312782
[TBL] [Abstract][Full Text] [Related]
10. Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene.
Westra D; Vernon KA; Volokhina EB; Pickering MC; van de Kar NC; van den Heuvel LP
J Hum Genet; 2012 Jul; 57(7):459-64. PubMed ID: 22622361
[TBL] [Abstract][Full Text] [Related]
11. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome.
Magro CM; Momtahen S; Mulvey JJ; Yassin AH; Kaplan RB; Laurence JC
Am J Dermatopathol; 2015 May; 37(5):349-56; quiz 357-9. PubMed ID: 25893747
[TBL] [Abstract][Full Text] [Related]
12. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome.
Bu F; Zhang Y; Wang K; Borsa NG; Jones MB; Taylor AO; Takanami E; Meyer NC; Frees K; Thomas CP; Nester C; Smith RJH
J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230
[TBL] [Abstract][Full Text] [Related]
13. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
[TBL] [Abstract][Full Text] [Related]
14. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
Pollack S; Eisenstein I; Mory A; Paperna T; Ofir A; Baris-Feldman H; Weiss K; Veszeli N; Csuka D; Shemer R; Glaser F; Prohászka Z; Magen D
Front Immunol; 2021; 12():608604. PubMed ID: 34248927
[TBL] [Abstract][Full Text] [Related]
15. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
Ueda Y; Miwa T; Ito D; Kim H; Sato S; Gullipalli D; Zhou L; Golla M; Song D; Dunaief JL; Palmer MB; Song WC
Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
[TBL] [Abstract][Full Text] [Related]
17. Complement Factor I Variants in Complement-Mediated Renal Diseases.
Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
Front Immunol; 2022; 13():866330. PubMed ID: 35619721
[TBL] [Abstract][Full Text] [Related]
18. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome.
Gholizad-Kolveiri S; Hooman N; Alizadeh R; Hoseini R; Otukesh H; Talebi S; Akouchekian M
BMC Med Genet; 2020 Aug; 21(1):169. PubMed ID: 32838746
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ
J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428
[TBL] [Abstract][Full Text] [Related]
20. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
Front Immunol; 2019; 10():853. PubMed ID: 31118930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
